Question explored with the scientific record
Cats claw
The short version: cat's claw has real anti-inflammatory chemistry and one small positive knee-arthritis trial, but the human evidence is thin and the products vary wildly.
The one human trial that matters here tested a different species than most supplements sell. Freeze-dried Uncaria guianensis improved knee-osteoarthritis pain and patient scores against placebo over four weeks, with no adverse effects reported [1]. That is a real clinical outcome, not a lab value, which counts for something. But it is a single small study, and the species is not the Uncaria tomentosa on most labels.
The rest is bench and animal work. Both species inhibit TNF-alpha and scavenge free radicals in the dish, and guianensis was actually more potent despite far lower alkaloid content [2]. A mouse paw-swelling model found the hydroalcoholic bark extract matched indomethacin at 50 mg/kg [7]. A 12-person human study of the aqueous extract C-Med-100 reported improved DNA repair and no adverse effects [6]. A 13-person HIV study saw lymphocyte counts rise [4]. Those are tiny samples and surrogate markers, not proof of feeling better or living longer.
| Extract | Alkaloids | TNF-alpha IC50 |
|---|---|---|
| U. tomentosa [2] | 9.04 mg/g | 14.1 ng/ml |
| U. guianensis [2] | 0.26 mg/g | 9.5 ng/ml |
The safety picture is short-term only. Rat and mouse lethal-dose testing put oral tolerance high [3][4], and a 28-day rat study at 1000 mg/kg/day showed no deaths but a kidney-weight increase and no clear no-effect level [4]. Alkaloid content swings enormously by plant part and origin [3][5], so two bottles labeled "cat's claw" can be different drugs. No long-term human safety data appears here.
My call: reasonable to try for knee osteoarthritis if you accept it is one small trial on a different species, not a proven treatment, and not something to take blind long-term. Confidence: low.
Sources used 7
-
Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis
This study evaluates the efficacy and safety of freeze-dried cat's claw (Uncaria guianensis) in treating knee osteoarthritis, demonstrating significant improvements in pain and assessment scores without adverse effects compared to placebo.
DOI: 10.1007/PL00000268 -
Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content
This study investigates the antioxidant and anti-inflammatory properties of two species of cat's claw, Uncaria tomentosa and Uncaria guianensis, revealing that U. guianensis exhibits greater potency in these activities independent of its lower alkaloid content.
DOI: 10.1078/0944-7113-00117 -
Unha-de-gato [Uncaria tomentosa (Willd.) DC. e Uncaria guianensis (Aubl.) Gmel.]: Um Panorama Sobre seus Aspectos mais Relevantes
Cat's claw species Uncaria tomentosa and Uncaria guianensis show immunomodulatory and anti-inflammatory activities driven by alkaloids and other constituents, but robust clinical evidence is limited and variability in extract composition and sustainability concerns complicate in…
DOI: 10.32712/2446-4775.2006.40 -
Uncaria tomentosa (Willd.) DC.—Ethnomedicinal use and new pharmacological, toxicological and botanical results
This study documents the Asháninka ethnomedical use of Uncaria tomentosa (cat's claw) and reports new pharmacological, toxicological, and botanical data, including chemotype differentiation of oxindole alkaloids and their effects on lymphocyte proliferation via endothelial-cell–…
DOI: 10.1016/s0378-8741(98)00096-8 -
Phenolic Assesment of Uncaria tomentosa L. (Cat’s Claw): Leaves, Stem, Bark and Wood Extracts
This study investigates the phenolic and alkaloid composition of Uncaria tomentosa L. (Cat's Claw) extracts from various parts of the plant using advanced analytical techniques, revealing a total of 32 identified phenolic compounds and significant variability in alkaloid content…
DOI: 10.3390/molecules201219875 -
DNA repair enhancement of aqueous extracts of in a human volunteer study
Twelve healthy adults were randomized to receive 0, 250 mg/day, or 350 mg/day of the aqueous Uncaria tomentosa extract C-Med-100 for 8 weeks to assess DNA repair and immune function, with findings showing increased DNA repair capacity and reduced DNA damage in the treated groups…
DOI: 10.1078/0944-7113-00045 -
Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae)
This study compares anti-inflammatory activity and mechanisms of two Uncaria tomentosa bark extracts in a carrageenan-induced mouse paw edema model and in vitro NF-kB and COX assays, finding the hydroalcoholic extract more active with limited COX inhibition and potential NF-kB s…
DOI: 10.1016/s0378-8741(02)00093-4